Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes (CROSBI ID 158547)

Prilog u časopisu | prikaz, osvrt, kritika

Marušić, Srećko ; Vlahović-Palčevski, Vera ; Ljubanović, Danica Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes // International journal of clinical pharmacology, therapy and toxicology, 47 (2009), 10; 603-605

Podaci o odgovornosti

Marušić, Srećko ; Vlahović-Palčevski, Vera ; Ljubanović, Danica

engleski

Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes

An increasing number of patients with both type 1 and type 2 diabetes are being prescribed insulin analogues. Insulin aspart has some pharmacokinetic advantages compared to unmodified human insulin. Faster absorption after subcutaneous administration and higher plasma levels resemble physiological meal-stimulated insulin release more closely than human insulin (1). Glycaemic control is improved with less interprandial and noctural hypoglycaemia (2). We present a patient experiencing vasculitis during the course of insulin aspart treatment. Literature search yielded no similar cases reported.

insulin aspart; vasculitis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

47 (10)

2009.

603-605

objavljeno

0300-9718

Povezanost rada

Kliničke medicinske znanosti